Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BLDR

Go back to Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 9c

August 1, 2019 5:52 PM EDT

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29).

We have had a highly productive second quarter at Iovance, commented Maria Fardis, Ph.D., MBA, president and chief executive officer of Iovance Biotherapeutics. We presented data for both... More